Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2013

01.07.2013 | Epidemiology

Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study

verfasst von: Victoria Blinder, Sujata Patil, Carolyn Eberle, Jennifer Griggs, Rose C. Maly

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Low-income women may be especially vulnerable to job loss after a breast cancer diagnosis. The identification of early risk factors for not returning to work in the long term could inform interventions to help survivors avoid this outcome. A consecutive sample of low-income, employed, underinsured/uninsured women treated for stage 0–III breast cancer was surveyed 6, 18, 36, and 60 months after diagnosis. Participants were classified according to the survey in which they first reported return to work. If they were not working in every survey they were classified as not returning to work. Correlates of not returning to work were identified. Of 274 participants, 36 % returned to work by 6 months, an additional 21 % by 18, 10 % by 36, and 5 % by 60 months. 27 % never returned to work. Of those not working at 6 months, 43 % never returned. Independent predictors of never returning to work included lowest annual income (<$10,000), Latina ethnicity, high comorbidity burden, and receipt of chemotherapy. Very poor women who stop working during chemotherapy for breast cancer are at risk of not returning to work months and years following treatment. These findings may have clinical and policy implications. Conversely, radiation therapy, axillary node dissection, age, and job type do not appear to be associated with return to work. Clinicians should discuss work-related concerns with patients and facilitate early return to work when desired by the patient. Additional research is needed to develop interventions to optimize return to work.
Literatur
1.
Zurück zum Zitat Blinder V, Patil S, Thind A, Diamant A, Hudis C, Basch E, Maly R (2012) Return to work in low-income latina non-latina white breast cancer survivors: a three-year longitudinal study. Cancer 118(6):1664–1674. doi:10.1002/cncr.26478 PubMedCrossRef Blinder V, Patil S, Thind A, Diamant A, Hudis C, Basch E, Maly R (2012) Return to work in low-income latina non-latina white breast cancer survivors: a three-year longitudinal study. Cancer 118(6):1664–1674. doi:10.​1002/​cncr.​26478 PubMedCrossRef
2.
Zurück zum Zitat Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life of breast cancer patients. Acta Oncol 42(7):710–718PubMedCrossRef Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life of breast cancer patients. Acta Oncol 42(7):710–718PubMedCrossRef
5.
Zurück zum Zitat Bouknight RR, Bradley CJ, Luo Z (2006) Correlates of return to work for breast cancer survivors. J Clin Oncol 24(3):345–353PubMedCrossRef Bouknight RR, Bradley CJ, Luo Z (2006) Correlates of return to work for breast cancer survivors. J Clin Oncol 24(3):345–353PubMedCrossRef
6.
Zurück zum Zitat Satariano WA, DeLorenze GN (1996) The likelihood of returning to work after breast cancer. Public Health Rep 111(3):236–241PubMed Satariano WA, DeLorenze GN (1996) The likelihood of returning to work after breast cancer. Public Health Rep 111(3):236–241PubMed
7.
Zurück zum Zitat Bradley CJ, Neumark D, Bednarek HL, Schenk M (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24(1):137–160PubMedCrossRef Bradley CJ, Neumark D, Bednarek HL, Schenk M (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24(1):137–160PubMedCrossRef
8.
Zurück zum Zitat Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 119(1):213–220. doi:10.1007/s10549-009-0389-y PubMedCrossRef Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 119(1):213–220. doi:10.​1007/​s10549-009-0389-y PubMedCrossRef
10.
Zurück zum Zitat Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M (2009) Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 45(4):625–633. doi:10.1016/j.ejca.2008.09.027 PubMedCrossRef Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M (2009) Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 45(4):625–633. doi:10.​1016/​j.​ejca.​2008.​09.​027 PubMedCrossRef
11.
Zurück zum Zitat Chen J, Diamant A, Thind A, Maly R (2008) Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer 112(5):1153–1161PubMedCrossRef Chen J, Diamant A, Thind A, Maly R (2008) Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer 112(5):1153–1161PubMedCrossRef
12.
Zurück zum Zitat Eremenco SL, Cella D, Arnold BJ (2005) A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 28(2):212–232PubMedCrossRef Eremenco SL, Cella D, Arnold BJ (2005) A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 28(2):212–232PubMedCrossRef
13.
Zurück zum Zitat Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94(1):39–49PubMedCrossRef Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94(1):39–49PubMedCrossRef
14.
Zurück zum Zitat Seeman TE, Berkman LF (1988) Structural characteristics of social networks and their relationship with social support in the elderly: who provides support. Soc Sci Med 26(7):737–749PubMedCrossRef Seeman TE, Berkman LF (1988) Structural characteristics of social networks and their relationship with social support in the elderly: who provides support. Soc Sci Med 26(7):737–749PubMedCrossRef
15.
Zurück zum Zitat Marin G, Sabogal F, Marin B, Otero-Sabogal R, Perez-Stable E (1987) Development of a short acculturation scale for hispanics. Hispanic J Behav Sci 9(2):183–205CrossRef Marin G, Sabogal F, Marin B, Otero-Sabogal R, Perez-Stable E (1987) Development of a short acculturation scale for hispanics. Hispanic J Behav Sci 9(2):183–205CrossRef
18.
Zurück zum Zitat Chirikos TN, Russell-Jacobs A, Cantor AB (2002) Indirect economic effects of long-term breast cancer survival. Cancer Pract 10(5):248–255PubMedCrossRef Chirikos TN, Russell-Jacobs A, Cantor AB (2002) Indirect economic effects of long-term breast cancer survival. Cancer Pract 10(5):248–255PubMedCrossRef
19.
Zurück zum Zitat Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G (2007) Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res 16(3):413–428PubMedCrossRef Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G (2007) Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res 16(3):413–428PubMedCrossRef
20.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
21.
Zurück zum Zitat Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73–84PubMedCrossRef Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73–84PubMedCrossRef
23.
Zurück zum Zitat Maly RC, Liu Y, Leake B, Thind A, Diamant AL (2010) Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat 119(3):707–716. doi:10.1007/s10549-009-0418-x PubMedCrossRef Maly RC, Liu Y, Leake B, Thind A, Diamant AL (2010) Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat 119(3):707–716. doi:10.​1007/​s10549-009-0418-x PubMedCrossRef
25.
Zurück zum Zitat Brown RF, Owens M, Bradley C (2013) Employee to employer communication skills: balancing cancer treatment and employment. Psychooncology 22(2):426–433. doi:10.1002/pon.2107 PubMed Brown RF, Owens M, Bradley C (2013) Employee to employer communication skills: balancing cancer treatment and employment. Psychooncology 22(2):426–433. doi:10.​1002/​pon.​2107 PubMed
26.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC
27.
Zurück zum Zitat Greenhouse S (2013) Labor sees bright spots in membership trends. The New York Times, January 28 Greenhouse S (2013) Labor sees bright spots in membership trends. The New York Times, January 28
Metadaten
Titel
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study
verfasst von
Victoria Blinder
Sujata Patil
Carolyn Eberle
Jennifer Griggs
Rose C. Maly
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2625-8

Weitere Artikel der Ausgabe 2/2013

Breast Cancer Research and Treatment 2/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.